Bio Protocol vs MultiversX — how do they compare? Bio Protocol trades at Rp514.26 (market cap Rp1,16T, Rp252,63M 24h volume), while MultiversX trades at Rp55,896 (market cap Rp1,69T, Rp150,83M 24h volume). The key difference: MultiversX is the larger of the two by market cap, and Bio Protocol's supply is capped (2,2B / 3,3B BIO (68%)) while MultiversX's keeps growing. Which is the better fit depends on your goals — on Pluang, investors hold Bio Protocol for 16 Days and MultiversX for 82 Days on average.
| BIO | EGLD | |
|---|---|---|
Market Cap | Rp1,16T | Rp1,69T |
Volume (24h) | Rp252,63M | Rp150,83M |
Circulating Supply | 2,2B / 3,3B BIO (68%) | 30,3M EGLD |
Typical Hold Time | 16 Days | 82 Days |
What Pluang investors did over the last 30 days
BIO Protocol enables global communities of scientists, patients, and investors to collectively fund, develop, and co-own new drugs and therapeutics through its network of Biotech Decentralized Autonomous Organizations (BioDAOs). The protocol's innovative approach addresses critical gaps in traditional scientific funding, particularly in areas such as rare diseases, longevity research, and emerging health challenges.
Read more on BIO →MultiversX (EGLD) is a blockchain protocol that seeks to offer extremely fast transaction speeds by using sharding. The project is known as a technology ecosystem for the new internet, which includes fintech, decentralized finance and the Internet of Things. The native token, EGLD, is used for paying network fees, staking and rewarding validators
Read more on EGLD →